ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 717838 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 717838; 2) Community: the network communities that were significantly associated with the response to NSC 717838; 3) Molecule: the relationships between components within communities and NSC 717838; 4) MDR: the compounds that were significantly associated with the NSC 717838.

NSC Compound Enrichment Correlation
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0396077140933377 -0.088172927
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0396077140933377 -0.017075872
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0396077140933377 0.050683989
NSC 254665 JUSTICIDIN B 0.0396077140933377 -0.15750394
NSC 269760 B8 0.0396077140933377 0.0043743111
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0396077140933377 -0.12864394
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0396077140933377 0.026523731
NSC 606497 Camptothecin Derivative 0.0396077140933377 -0.065699068
NSC 615291 Bizelesin 0.0396077140933377 -0.097329546
NSC 615534 Null 0.0396077140933377 0.27905925
Total:55  Current:44    [First] [Prev] [Next] [Last]